Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * SITEMAP: |
Title | POLIVY® (polatuzumab vedotin-piiq) Indications, Efficacy, Dosing and |
Description | In first-line DLBCL, NOS or HGBL and IPI ≥ Learn about POLIVY® (polatuzumab vedotin-piiq) in combination with a rituximab product, cyclophosphamide, doxorubicin, and prednisone (R-CHP) for the treatment of adult patients with previously untreated diffuse large B-cell lymphoma (DLBCL). See |
Keywords | N/A |
WebSite | polivy.com |
Host IP | 104.18.12.226 |
Location | Singapore |
Site | Rank |
US$18,409,789
Last updated: 2023-05-11 11:01:57
polivy.com has Semrush global rank of 574,928. polivy.com has an estimated worth of US$ 18,409,789, based on its estimated Ads revenue. polivy.com receives approximately 2,124,207 unique visitors each day. Its web server is located in Singapore, with IP address 104.18.12.226. According to SiteAdvisor, polivy.com is safe to visit. |
Purchase/Sale Value | US$18,409,789 |
Daily Ads Revenue | US$16,994 |
Monthly Ads Revenue | US$509,810 |
Yearly Ads Revenue | US$6,117,715 |
Daily Unique Visitors | 141,614 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
polivy.com. | A | 299 | IP: 104.18.12.226 |
polivy.com. | A | 299 | IP: 104.18.13.226 |
polivy.com. | AAAA | 299 | IPV6: 2606:4700::6812:de2 |
polivy.com. | AAAA | 299 | IPV6: 2606:4700::6812:ce2 |
polivy.com. | NS | 86400 | NS Record: alan.ns.cloudflare.com. |
polivy.com. | NS | 86400 | NS Record: lara.ns.cloudflare.com. |
polivy.com. | TXT | 300 | TXT Record: vgbb0t997wt3ds40pphr729n950tbtqx |
For Patients and Caregivers Prescribing Information Prescribing Information Contact a Representative Contact a Representative Other Indications Other Indications Safety Safety MENU Prescribing Information Contact a Representative Other Indications Safety For Patients and Caregivers In first-line DLBCL, NOS or HGBL and IPI ≥ 2 1 In first-line DLBCL, NOS or HGBL and IPI ≥ 2 1 POLIVY ® + R-CHP: Superior Progression-Free Survival (PFS) vs R-CHOP 1 in the ITT population (HR [95% CI]: 0.73 [0.57, 0.95], p=0.0177) POLARIX: A double-blind, placebo-controlled randomized, multicenter, phase III study that evaluated the efficacy and safety of POLIVY + R-CHP (n=440) vs R-CHOP (n=439). Eligible patients had DLBCL, NOS or HGBL, or other large B-cell lymphoma (including EBV+ DLBCL, NOS and T-cell/histiocyte rich LBCL), and IPI ≥ 2. Primary endpoint was investigator assessed PFS. 1 POLIVY ® + R-CHP: Superior Progression-Free Survival (PFS) vs R-CHOP 1 in the ITT population (HR [95% CI]: 0.73 [0.57, |
HTTP/1.1 301 Moved Permanently Date: Thu, 04 Nov 2021 15:00:59 GMT Connection: keep-alive Cache-Control: max-age=3600 Expires: Thu, 04 Nov 2021 16:00:59 GMT Location: https://polivy.com/ Set-Cookie: __cfruid=57fb07d85bb7563c558bbbb320ff286ee6fd378a-1636038059; path=/; domain=.polivy.com; HttpOnly Server: cloudflare CF-RAY: 6a8eb70feb4061b6-ORD HTTP/2 301 date: Thu, 04 Nov 2021 15:00:59 GMT content-type: text/html; charset=iso-8859-1 location: https://www.polivy.com/ cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" set-cookie: __cfruid=57fb07d85bb7563c558bbbb320ff286ee6fd378a-1636038059; path=/; domain=.polivy.com; HttpOnly; Secure; SameSite=None server: cloudflare cf-ray: 6a8eb71058bbfdcd-ORD HTTP/2 200 date: Thu, 04 Nov 2021 15:01:00 GMT content-type: text/html; charset=UTF-8 vary: Accept-Encoding cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" set-cookie: __cfruid=56025fa7d1ea2a579a3ad8d2da4c21c4d2fd0633-1636038060; path=/; domain=.polivy.com; HttpOnly; Secure; SameSite=None server: cloudflare cf-ray: 6a8eb7129ab76374-ORD |
Domain Name: POLIVY.COM Registry Domain ID: 2361806069_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.safenames.net Registrar URL: http://www.safenames.net Updated Date: 2021-06-23T13:16:34Z Creation Date: 2019-02-18T19:02:04Z Registry Expiry Date: 2023-02-18T19:02:04Z Registrar: SafeNames Ltd. Registrar IANA ID: 447 Registrar Abuse Contact Email: abuse@safenames.net Registrar Abuse Contact Phone: +44.1908200022 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: ALAN.NS.CLOUDFLARE.COM Name Server: LARA.NS.CLOUDFLARE.COM DNSSEC: unsigned >>> Last update of whois database: 2021-10-27T06:01:32Z <<< |